PDB Short entry for 5EU8 HEADER HYDROLASE/HYDROLASE INHIBITOR 18-NOV-15 5EU8 TITLE STRUCTURE OF FIPV MAIN PROTEASE IN COMPLEX WITH DUAL INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAIN PROTEASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- COMPND 7 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3- COMPND 8 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FELINE INFECTIOUS PERITONITIS VIRUS; SOURCE 3 ORGANISM_COMMON: FIPV; SOURCE 4 ORGANISM_TAXID: 11135; SOURCE 5 GENE: 1B, ORF1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630 KEYWDS FIPV, MAIN PROTEASE, DUAL INHIBITORS, ZINC, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.WANG,C.CHEN,X.LIU,K.YANG,X.XU,H.YANG REVDAT 4 15-NOV-23 5EU8 1 LINK ATOM REVDAT 3 08-NOV-23 5EU8 1 JRNL REMARK REVDAT 2 10-FEB-16 5EU8 1 JRNL REVDAT 1 30-DEC-15 5EU8 0 JRNL AUTH F.WANG,C.CHEN,X.LIU,K.YANG,X.XU,H.YANG JRNL TITL CRYSTAL STRUCTURE OF FELINE INFECTIOUS PERITONITIS VIRUS JRNL TITL 2 MAIN PROTEASE IN COMPLEX WITH SYNERGETIC DUAL INHIBITORS JRNL REF J.VIROL. V. 90 1910 2015 JRNL REFN ESSN 1098-5514 JRNL PMID 26656689 JRNL DOI 10.1128/JVI.02685-15 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 12061 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 589 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.9445 - 3.8841 0.95 2902 150 0.1946 0.2173 REMARK 3 2 3.8841 - 3.0832 0.98 2851 143 0.2087 0.2291 REMARK 3 3 3.0832 - 2.6935 0.99 2851 148 0.2464 0.2980 REMARK 3 4 2.6935 - 2.4473 0.99 2868 148 0.2472 0.3298 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.750 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2403 REMARK 3 ANGLE : 1.171 3253 REMARK 3 CHIRALITY : 0.044 360 REMARK 3 PLANARITY : 0.005 419 REMARK 3 DIHEDRAL : 14.669 849 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 0:188) REMARK 3 ORIGIN FOR THE GROUP (A): -33.4962 -14.9306 -10.8463 REMARK 3 T TENSOR REMARK 3 T11: 0.3878 T22: 0.3101 REMARK 3 T33: 0.3852 T12: 0.0179 REMARK 3 T13: -0.0262 T23: 0.0193 REMARK 3 L TENSOR REMARK 3 L11: 1.1803 L22: 2.2198 REMARK 3 L33: 1.6916 L12: 0.3795 REMARK 3 L13: 0.7460 L23: 0.6236 REMARK 3 S TENSOR REMARK 3 S11: -0.0696 S12: 0.0611 S13: 0.1775 REMARK 3 S21: -0.1890 S22: -0.0319 S23: 0.1765 REMARK 3 S31: -0.1945 S32: -0.0617 S33: 0.0001 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 189:270) REMARK 3 ORIGIN FOR THE GROUP (A): -37.3906 -48.0220 -16.5915 REMARK 3 T TENSOR REMARK 3 T11: 0.5233 T22: 0.4179 REMARK 3 T33: 0.4285 T12: 0.0090 REMARK 3 T13: -0.0446 T23: 0.0178 REMARK 3 L TENSOR REMARK 3 L11: 0.9641 L22: 0.7390 REMARK 3 L33: 1.1004 L12: -0.1300 REMARK 3 L13: 0.0716 L23: -0.4448 REMARK 3 S TENSOR REMARK 3 S11: -0.0496 S12: 0.1790 S13: 0.0481 REMARK 3 S21: -0.1585 S22: -0.0440 S23: 0.2108 REMARK 3 S31: 0.4009 S32: 0.0301 S33: 0.0000 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 271:299) REMARK 3 ORIGIN FOR THE GROUP (A): -33.4766 -43.7898 -6.9226 REMARK 3 T TENSOR REMARK 3 T11: 0.4113 T22: 0.4723 REMARK 3 T33: 0.4185 T12: -0.0104 REMARK 3 T13: 0.0358 T23: 0.0058 REMARK 3 L TENSOR REMARK 3 L11: 0.2612 L22: 0.5392 REMARK 3 L33: 0.1196 L12: -0.1732 REMARK 3 L13: -0.1412 L23: 0.2317 REMARK 3 S TENSOR REMARK 3 S11: -0.3073 S12: -0.0355 S13: 0.0230 REMARK 3 S21: 0.0088 S22: 0.2116 S23: -0.0576 REMARK 3 S31: 0.0401 S32: 0.1071 S33: -0.0004 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EU8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215425. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JAN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97923 REMARK 200 MONOCHROMATOR : DCM REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SCALEPACK REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12082 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.447 REMARK 200 RESOLUTION RANGE LOW (A) : 42.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 31.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2AMP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M ZINC ACETATE DIHYDRATE, 0.1 M REMARK 280 SODIUM CACODYLATE TRIHYDRATE, 14%(W/V) POLYETHYLENE GLYCOL 8000, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 11555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 12555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 13555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 14555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 15555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 56.13050 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 51.05100 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 56.13050 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 51.05100 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 56.13050 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 51.05100 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 56.13050 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 51.05100 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 56.13050 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 51.05100 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 56.13050 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 51.05100 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 56.13050 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 51.05100 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 56.13050 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 56.13050 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 51.05100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -105.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 532 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 590 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)- REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL) REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R, REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 ASN A 300 REMARK 465 LEU A 301 REMARK 465 GLN A 302 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 511 O HOH A 576 1.85 REMARK 500 OH TYR A 125 O HOH A 501 1.89 REMARK 500 OE1 GLU A 165 O HOH A 502 1.90 REMARK 500 O HOH A 503 O HOH A 573 2.04 REMARK 500 OE2 GLU A 165 NE2 HIS A 171 2.04 REMARK 500 OD1 ASP A 285 O HOH A 503 2.07 REMARK 500 O GLU A 56 O HOH A 504 2.07 REMARK 500 O SER A 138 O HOH A 505 2.07 REMARK 500 OE1 GLU A 215 O HOH A 506 2.13 REMARK 500 ND1 HIS A 63 O HOH A 507 2.14 REMARK 500 O GLY A 2 O HOH A 508 2.15 REMARK 500 O HOH A 560 O HOH A 567 2.16 REMARK 500 OE2 GLU A 99 O HOH A 509 2.19 REMARK 500 O HOH A 603 O HOH A 609 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 SG CYS A 120 O HOH A 507 6555 2.02 REMARK 500 O HOH A 582 O HOH A 601 6555 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL B 3 C LEU B 4 N 0.160 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 46 146.91 -170.23 REMARK 500 ASN A 70 -126.21 57.63 REMARK 500 ASN A 153 14.12 82.28 REMARK 500 HIS A 163 -81.35 -124.74 REMARK 500 ASP A 186 47.27 -70.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 41 NE2 REMARK 620 2 HIS A 163 ND1 93.6 REMARK 620 3 ASP A 186 OD1 93.9 87.5 REMARK 620 4 HOH A 558 O 110.9 121.4 139.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE DBREF 5EU8 A 1 302 UNP V9PIT1 V9PIT1_9ALPC 2904 3205 DBREF 5EU8 B 1 6 PDB 5EU8 5EU8 1 6 SEQADV 5EU8 GLY A -4 UNP V9PIT1 EXPRESSION TAG SEQADV 5EU8 PRO A -3 UNP V9PIT1 EXPRESSION TAG SEQADV 5EU8 LEU A -2 UNP V9PIT1 EXPRESSION TAG SEQADV 5EU8 GLY A -1 UNP V9PIT1 EXPRESSION TAG SEQADV 5EU8 SER A 0 UNP V9PIT1 EXPRESSION TAG SEQRES 1 A 307 GLY PRO LEU GLY SER SER GLY LEU ARG LYS MET ALA GLN SEQRES 2 A 307 PRO SER GLY VAL VAL GLU PRO CYS ILE VAL ARG VAL ALA SEQRES 3 A 307 TYR GLY ASN ASN VAL LEU ASN GLY LEU TRP LEU GLY ASP SEQRES 4 A 307 GLU VAL ILE CYS PRO ARG HIS VAL ILE ALA SER ASP THR SEQRES 5 A 307 SER ARG VAL ILE ASN TYR GLU ASN GLU LEU SER SER VAL SEQRES 6 A 307 ARG LEU HIS ASN PHE SER ILE ALA LYS ASN ASN ALA PHE SEQRES 7 A 307 LEU GLY VAL VAL SER ALA LYS TYR LYS GLY VAL ASN LEU SEQRES 8 A 307 VAL LEU LYS VAL ASN GLN VAL ASN PRO ASN THR PRO GLU SEQRES 9 A 307 HIS LYS PHE LYS SER VAL ARG PRO GLY GLU SER PHE ASN SEQRES 10 A 307 ILE LEU ALA CYS TYR GLU GLY CYS PRO GLY SER VAL TYR SEQRES 11 A 307 GLY VAL ASN MET ARG SER GLN GLY THR ILE LYS GLY SER SEQRES 12 A 307 PHE ILE ALA GLY THR CYS GLY SER VAL GLY TYR VAL LEU SEQRES 13 A 307 GLU ASN GLY THR LEU TYR PHE VAL TYR MET HIS HIS LEU SEQRES 14 A 307 GLU LEU GLY ASN GLY SER HIS VAL GLY SER ASN LEU GLU SEQRES 15 A 307 GLY GLU MET TYR GLY GLY TYR GLU ASP GLN PRO SER MET SEQRES 16 A 307 GLN LEU GLU GLY THR ASN VAL MET SER SER ASP ASN VAL SEQRES 17 A 307 VAL ALA PHE LEU TYR ALA ALA LEU ILE ASN GLY GLU ARG SEQRES 18 A 307 TRP PHE VAL THR ASN THR SER MET THR LEU GLU SER TYR SEQRES 19 A 307 ASN ALA TRP ALA LYS THR ASN SER PHE THR GLU ILE VAL SEQRES 20 A 307 SER THR ASP ALA PHE ASN MET LEU ALA ALA LYS THR GLY SEQRES 21 A 307 TYR SER VAL GLU LYS LEU LEU GLU CYS ILE VAL ARG LEU SEQRES 22 A 307 ASN LYS GLY PHE GLY GLY ARG THR ILE LEU SER TYR GLY SEQRES 23 A 307 SER LEU CYS ASP GLU PHE THR PRO THR GLU VAL ILE ARG SEQRES 24 A 307 GLN MET TYR GLY VAL ASN LEU GLN SEQRES 1 B 6 02J ALA VAL LEU PJE 010 HET 02J B 1 8 HET PJE B 5 13 HET 010 B 6 8 HET ZN A 401 1 HET EDO A 402 4 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL HETNAM ZN ZINC ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 02J C5 H5 N O3 FORMUL 2 PJE C9 H14 N2 O3 FORMUL 2 010 C7 H8 O FORMUL 3 ZN ZN 2+ FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *110(H2 O) HELIX 1 AA1 VAL A 13 PRO A 15 5 3 HELIX 2 AA2 HIS A 41 ILE A 43 5 3 HELIX 3 AA3 ASN A 52 SER A 59 1 8 HELIX 4 AA4 ARG A 61 HIS A 63 5 3 HELIX 5 AA5 MET A 180 TYR A 184 5 5 HELIX 6 AA6 SER A 199 GLY A 214 1 16 HELIX 7 AA7 THR A 225 THR A 235 1 11 HELIX 8 AA8 THR A 244 ALA A 246 5 3 HELIX 9 AA9 PHE A 247 GLY A 255 1 9 HELIX 10 AB1 SER A 257 ASN A 269 1 13 HELIX 11 AB2 THR A 288 TYR A 297 1 10 SHEET 1 AA1 7 ALA A 72 LEU A 74 0 SHEET 2 AA1 7 PHE A 65 LYS A 69 -1 N LYS A 69 O ALA A 72 SHEET 3 AA1 7 ILE A 17 TYR A 22 -1 N ALA A 21 O SER A 66 SHEET 4 AA1 7 ASN A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA1 7 GLU A 35 PRO A 39 -1 O ILE A 37 N LEU A 30 SHEET 6 AA1 7 ASN A 85 VAL A 90 -1 O LEU A 86 N CYS A 38 SHEET 7 AA1 7 VAL A 76 SER A 78 -1 N VAL A 77 O LYS A 89 SHEET 1 AA2 7 ALA A 72 LEU A 74 0 SHEET 2 AA2 7 PHE A 65 LYS A 69 -1 N LYS A 69 O ALA A 72 SHEET 3 AA2 7 ILE A 17 TYR A 22 -1 N ALA A 21 O SER A 66 SHEET 4 AA2 7 ASN A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA2 7 GLU A 35 PRO A 39 -1 O ILE A 37 N LEU A 30 SHEET 6 AA2 7 ASN A 85 VAL A 90 -1 O LEU A 86 N CYS A 38 SHEET 7 AA2 7 TYR A 81 LYS A 82 -1 N LYS A 82 O ASN A 85 SHEET 1 AA3 5 LYS A 101 PHE A 102 0 SHEET 2 AA3 5 THR A 155 GLU A 165 1 O PHE A 158 N LYS A 101 SHEET 3 AA3 5 VAL A 147 GLU A 152 -1 N GLU A 152 O THR A 155 SHEET 4 AA3 5 SER A 110 TYR A 117 -1 N ASN A 112 O TYR A 149 SHEET 5 AA3 5 CYS A 120 ASN A 128 -1 O GLY A 122 N ALA A 115 SHEET 1 AA4 3 LYS A 101 PHE A 102 0 SHEET 2 AA4 3 THR A 155 GLU A 165 1 O PHE A 158 N LYS A 101 SHEET 3 AA4 3 HIS A 171 SER A 174 -1 O VAL A 172 N LEU A 164 LINK SG CYS A 144 C20 PJE B 5 1555 1555 1.73 LINK C 02J B 1 N ALA B 2 1555 1555 1.43 LINK C LEU B 4 N PJE B 5 1555 1555 1.45 LINK C PJE B 5 O 010 B 6 1555 1555 1.41 LINK NE2 HIS A 41 ZN ZN A 401 1555 1555 2.04 LINK ND1 HIS A 163 ZN ZN A 401 1555 1555 2.42 LINK OD1 ASP A 186 ZN ZN A 401 1555 1555 2.10 LINK ZN ZN A 401 O HOH A 558 1555 1555 2.19 CISPEP 1 ASN A 153 GLY A 154 0 -13.35 SITE 1 AC1 4 HIS A 41 HIS A 163 ASP A 186 HOH A 558 SITE 1 AC2 3 SER A 104 GLU A 179 HOH A 532 SITE 1 AC3 16 ASN A 25 VAL A 26 HIS A 41 CYS A 144 SITE 2 AC3 16 HIS A 162 HIS A 163 LEU A 164 GLU A 165 SITE 3 AC3 16 GLY A 167 GLN A 187 PRO A 188 SER A 189 SITE 4 AC3 16 MET A 190 ALA A 252 LYS A 253 HOH A 574 CRYST1 112.261 112.261 102.102 90.00 90.00 90.00 I 4 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008908 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008908 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009794 0.00000